About UsVisionSynageva BioPharma is a clinical stage biopharmaceutical company dedicated to discovering, developing and delivering medicines for patients with rare disease and unmet medical need. At Synageva, we share a passion and commitment to improving the lives of patients with rare diseases. Our team is drawn from leading biotech companies and has helped bring several life-saving therapies to patients whose diseases were once considered too rare for developing treatments. We believe that every patient deserves treatment options, regardless of the rarity of their disease.ProgramsOur lead…
Barnes Healthcare Services was founded in 1909 by Charles W. Barnes, Rph. in a corner drug store in Valdosta, Georgia. In those days medications were compounded by hand and the horse was the main mode of transportation. In 1946 Barnes supplied its first patient with a hospital bed, oxygen and a wheelchair. The business has been passed down through three generations to Charles W. Barnes, III whose vision, dedication to the patient, and desire to be the best provider in the area has grown the business to 21 locations in Georgia, Florida, and Alabama.
Alba Biologics Group is a leading biopharmaceutical strategic and technical support group providing consulting and management services to start-ups, early product developers and established industry leaders. With 20 years experience Alba Biologics leverages the expertise of the founder and our associates to help clients advance drug candidates from the bench through to regulatory approval. Alba will support client organizations on both short and long term projects working with a clientпїЅs in house staff as well as integrating with contract service providers.Alba Biologics brings to the…
OverviewFibeRio Technology Corp. ("FibeRio" or the "Company") has developed revolutionary Forcespinning™ technology to produce nanofibers at commercial scale. This Forcespinning approach has the potential to replace 50+ year old electrospinning technology which is an order of magnitude less productive, over 4x more expensive, limiting in terms of materials and volume capabilities, and results in hazardous waste and disposal issues. The market and applications for nanofibers is expected to grow dramatically over the next 10 years across almost every industry (filtration, energy, textiles,…
MediNatura is dedicated to manufacturing and distributing high quality, FDA regulated products. We know people can improve their lives by making healthy lifestyle choices, healthy food choices and healthy medicine choices. MediNatura's mission is to improve lives with medicines from nature.
Bristol-Myers Squibb is a global BioPharma company firmly focused on its Mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis and psychiatric disorders.At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this…
Solabia Group: Converging Bio-Expertise and Sustainable Innovation. Having invested in the Cosmetics, Pharmaceutical, Nutritional, Diagnostics and Biotechnology sectors, Solabia benefits from a coherent ensemble of converging know-how that allows us to reach our goal : satisfy your needs! Our 5 Sectors: - Cosmetics - Pharmaceutical - Nutritional - Diagnostics - Biotechnology
We are engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Controlled-release means releasing a drug into the bloodstream or at a target site in the body, over an extended period of time or at predetermined times. In some circumstances, controlled-release drug delivery can enhance efficacy and patient compliance as compared to immediate release formats for the same drug.Our proprietary Hypermatrix™ technology is at the core of our controlled-release drug delivery approach. The flexibility of the Hypermatrix™ technology…
Neuronasal develops drugs, delivered intranasally, for acute brain injuries. Our first products are for concussion. Neuronasal was founded to create value for patients and investors by licensing and developing drugs to treat acute brain injuries and disease. We plan to develop each of our drugs to proof of concept and then enter into strategic partnerships or trade sales. Neuronasal’s first two products are repurposed off patent drugs, deferoxamine and N acetyl cysteine, that we will deliver with existing intranasal delivery devices in clinical trials for concussion and intracerebral…
VBI Vaccines Inc. (Nasdaq: VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic the target virus. The company’s lead eVLP asset is a prophylactic Cytomegalovirus (“CMV”) vaccine; VBI has initiated work for GMP manufacturing of its CMV candidate for use in formal preclinical and Phase I trials. The company’s second platform is a thermostable technology that enables the…
SBH Sciences, Inc. was founded in 1997 with the sole purpose of producing mammalian-derived recombinant cytokines. Today, we have drastically expanded our services to offer cytokine-measuring bioassays, in vitro anti-cancer and anti-inflammation lead drug development, as well as the development of ELISA kits and Multiplex analyses.In the last year, we have continued our diversification and through partnerships with several companies, our product line now includes specific enzymes, specific kinase activity analysis and in vivo cancer models.SBH Sciences has been an innovator in the…
Lipella Pharmaceuticals Inc. is a privately held development-stage biotechnology company dedicated to improve patient care by developing novel products which focus on trans-mucosal therapy, delivering local treatments directly to their site of action. Lipella focuses on four therapeutic areas: urology, otorhinolaryngology, gastroenterology, and dermatology. In each of these areas, Lipella has liposomal therapies in various stages of development ranging from pre-clinical to early clinical in the U.S. and overseas.
Suntec Corporation was established in 2005 in Southern California, USA. We engage in the business of biotech, medical device and drug development. With a few years of perseverance and persistence, we have experienced rapid growth and significant success in global leadership of pharmaceutical markets.
Solid international business leader in small, mid, and large organizations. Significant global operations and business development expertise ranging from an early relationship initiation phase through culmination in a win win outcome. Strategic thinker with demonstrated execution experience with favorable P&L impact. Multilingual. Innovative.
Innoveas International is a leading innovation company, transforming world class technologies and innovative scientific ideas from universities and public research Institutions in Germany into game-changing enterprises. The company invests in high impact innovations in the global healthcare, energy, digital and environmental sectors.
Versante International, LLC is a leader in providing Biometrics related services to the Pharmaceutical and Biotech clinical development stage companies. Our team of proven experts in Biostatistics, SAS Programming and Data Management has extensive experience across a wide range of therapeutic areas. Work with Versante and benefit from shorter development times, enhanced product quality and reduced regulatory review cycles.
Venture Development FirmInnovation TechnologyVenture Capital FormationStrategic Growth & RelationsAgile Accelerated DevelopmentBiotech, Life Science, Medical Device, Food/Agri/Aqua, Controls/Instruments, Software/Data, Cleantech
Epione Biopharmaceuticals was formed to provide the benefits of highly efficacious, injectable medications for the treatment of pain in multiple markets without the burden and risks that opiate-based therapies offer. The worldwide incidence of acute and chronic pain, and the growing occurrence of migraine have lead to widespread consequences for both the healthcare system and the economy. First-line pain treatments are typically opiate-based medications; however, concerns regarding side effects, prescription drug abuse, risk of overdose, patient non-adherence to treatment regimens…
NormOxys, Inc., is a biotechnology company developing a new class of small molecule drugs which are derivatives of polyol phosphates. This platform promises to offer breakthrough treatments for a wide variety of cancers.
About Pharma Consult GlobalPharma Consult Global is your Preferred Partner for providing a quality solution for technical support services to the pharmaceutical industry.We were formed in 2013 Pharma Consult Global Ltd by four leading International Pharmaceutical Specialists, to provide best practices standards in pharmaceutical science and technical support to Pharmaceutical Companies globally and, particularly, to those operating in the emerging markets.Our highly qualified team has an outstanding track record of delivering successful projects across the following areas:Product…
